NRXS
Price
$2.65
Change
+$0.02 (+0.76%)
Updated
Dec 12 closing price
Capitalization
28.23M
Intraday BUY SELL Signals
RLMD
Price
$4.06
Change
-$0.13 (-3.10%)
Updated
Dec 12 closing price
Capitalization
297.73M
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXS vs RLMD

Header iconNRXS vs RLMD Comparison
Open Charts NRXS vs RLMDBanner chart's image
Neuraxis
Price$2.65
Change+$0.02 (+0.76%)
Volume$40.12K
Capitalization28.23M
Relmada Therapeutics
Price$4.06
Change-$0.13 (-3.10%)
Volume$1.62M
Capitalization297.73M
NRXS vs RLMD Comparison Chart in %
NRXS
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRXS vs. RLMD commentary
Dec 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Hold and RLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 15, 2025
Stock price -- (NRXS: $2.63 vs. RLMD: $4.19)
Brand notoriety: NRXS and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 9% vs. RLMD: 148%
Market capitalization -- NRXS: $28.23M vs. RLMD: $297.73M
NRXS [@Biotechnology] is valued at $28.23M. RLMD’s [@Biotechnology] market capitalization is $297.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whileRLMD’s FA Score has 0 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • RLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXS is a better buy in the long-term than RLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 3 TA indicator(s) are bullish while RLMD’s TA Score has 4 bullish TA indicator(s).

  • NRXS’s TA Score: 3 bullish, 5 bearish.
  • RLMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLMD is a better buy in the short-term than NRXS.

Price Growth

NRXS (@Biotechnology) experienced а -2.95% price change this week, while RLMD (@Biotechnology) price change was +4.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

RLMD is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLMD($298M) has a higher market cap than NRXS($28.2M). RLMD YTD gains are higher at: 705.769 vs. NRXS (11.915). NRXS has higher annual earnings (EBITDA): -7.45M vs. RLMD (-57.84M). RLMD has more cash in the bank: 13.9M vs. NRXS (4.38M). RLMD has less debt than NRXS: RLMD (256K) vs NRXS (478K). NRXS has higher revenues than RLMD: NRXS (3.36M) vs RLMD (0).
NRXSRLMDNRXS / RLMD
Capitalization28.2M298M9%
EBITDA-7.45M-57.84M13%
Gain YTD11.915705.7692%
P/E RatioN/AN/A-
Revenue3.36M0-
Total Cash4.38M13.9M31%
Total Debt478K256K187%
FUNDAMENTALS RATINGS
RLMD: Fundamental Ratings
RLMD
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXSRLMD
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 27 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EOSE16.441.65
+11.16%
Eos Energy Enterprises
PX10.380.17
+1.67%
P10
WMB60.920.42
+0.69%
Williams Companies
HIND4.77-0.08
-1.65%
Vyome Holdings Inc
TSSI8.30-0.17
-2.01%
TSS.Inc

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-4.71%
CVM - NRXS
58%
Loosely correlated
-0.77%
MRVI - NRXS
29%
Poorly correlated
-0.54%
RLMD - NRXS
28%
Poorly correlated
-5.20%
RGNX - NRXS
27%
Poorly correlated
-1.61%
PDSB - NRXS
25%
Poorly correlated
-0.98%
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENSC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-5.20%
ENSC - RLMD
38%
Loosely correlated
-10.13%
SYRE - RLMD
36%
Loosely correlated
-0.87%
PLUR - RLMD
33%
Loosely correlated
-12.71%
PRTC - RLMD
31%
Poorly correlated
+0.59%
AVXL - RLMD
31%
Poorly correlated
+0.74%
More